XML 14 R2.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2019
Dec. 31, 2018
ASSETS:    
Cash and cash equivalents $ 41.3 $ 25.7
Restricted cash and cash equivalents 417.9 303.6
Restricted securities available for sale [1] 62.0 58.6
Loans receivable 6,617.9 6,225.2
Allowance for credit losses (474.2) (461.9)
Loans receivable, net 6,143.7 5,763.3
Property and equipment, net 43.4 40.2
Income taxes receivable 7.5 7.9
Other assets 34.1 38.1
Total Assets 6,749.9 6,237.4
Liabilities:    
Accounts payable and accrued liabilities 192.0 186.4
Revolving secured line of credit 0.0 171.9
Secured financing 3,280.5 3,092.7
Senior notes 939.1 544.4
Mortgage note [2] 11.7 11.9
Deferred income taxes, net 256.3 236.7
Income taxes payable 21.4 2.5
Total Liabilities 4,701.0 4,246.5
Commitments and Contingencies - See Note 15
Shareholders' Equity:    
Preferred stock, $0.01 par value, 1,000,000 shares authorized, none issued 0.0 0.0
Common stock, $0.01 par value, 80,000,000 shares authorized, 18,797,071 and 18,972,558 shares issued and outstanding as of March 31, 2019 and December 31, 2018, respectively 0.2 0.2
Paid-in capital 152.2 154.9
Retained earnings 1,896.2 1,836.1
Accumulated other comprehensive gain (loss) 0.3 (0.3)
Total Shareholders' Equity 2,048.9 1,990.9
Total Liabilities and Shareholders' Equity $ 6,749.9 $ 6,237.4
[1] Measured at fair value on a recurring basis.
[2] Measured at amortized cost with fair value disclosed.